JP2003513003A5 - - Google Patents

Download PDF

Info

Publication number
JP2003513003A5
JP2003513003A5 JP2000554345A JP2000554345A JP2003513003A5 JP 2003513003 A5 JP2003513003 A5 JP 2003513003A5 JP 2000554345 A JP2000554345 A JP 2000554345A JP 2000554345 A JP2000554345 A JP 2000554345A JP 2003513003 A5 JP2003513003 A5 JP 2003513003A5
Authority
JP
Japan
Prior art keywords
sugar
iii
drying
reagent
vesicles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000554345A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003513003A (ja
JP4567882B2 (ja
Filing date
Publication date
Priority claimed from GBGB9813100.6A external-priority patent/GB9813100D0/en
Application filed filed Critical
Publication of JP2003513003A publication Critical patent/JP2003513003A/ja
Publication of JP2003513003A5 publication Critical patent/JP2003513003A5/ja
Application granted granted Critical
Publication of JP4567882B2 publication Critical patent/JP4567882B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000554345A 1998-06-18 1999-06-16 リポソームの製造方法 Expired - Lifetime JP4567882B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9813100.6A GB9813100D0 (en) 1998-06-18 1998-06-18 Method of forming liposomes
GB9813100.6 1998-06-18
PCT/GB1999/001911 WO1999065465A1 (en) 1998-06-18 1999-06-16 Method of forming liposomes

Publications (3)

Publication Number Publication Date
JP2003513003A JP2003513003A (ja) 2003-04-08
JP2003513003A5 true JP2003513003A5 (enExample) 2006-08-10
JP4567882B2 JP4567882B2 (ja) 2010-10-20

Family

ID=10833946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000554345A Expired - Lifetime JP4567882B2 (ja) 1998-06-18 1999-06-16 リポソームの製造方法

Country Status (15)

Country Link
US (1) US9675554B1 (enExample)
EP (1) EP1087754B1 (enExample)
JP (1) JP4567882B2 (enExample)
KR (1) KR100658956B1 (enExample)
CN (1) CN1312707A (enExample)
AT (1) ATE287258T1 (enExample)
AU (1) AU749499B2 (enExample)
CA (1) CA2335183A1 (enExample)
DE (1) DE69923315T2 (enExample)
GB (2) GB9813100D0 (enExample)
NO (1) NO20006442L (enExample)
NZ (1) NZ508960A (enExample)
RU (1) RU2216315C2 (enExample)
WO (1) WO1999065465A1 (enExample)
ZA (1) ZA200007507B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE341310T1 (de) * 2000-02-04 2006-10-15 Lipoxen Technologies Ltd Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
WO2002038128A1 (fr) * 2000-11-10 2002-05-16 Japan Science And Technology Corporation Procede de preparation d'une dispersion de microsome
AU3652602A (en) * 2000-11-15 2002-05-27 Us Gov Health & Human Serv Sol-fusin: use of gp64-6his to catalyze membrane fusion
BRPI0105509B8 (pt) 2001-11-05 2021-05-25 Univ Minas Gerais formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
US7285289B2 (en) * 2002-04-12 2007-10-23 Nagy Jon O Nanoparticle vaccines
KR100482355B1 (ko) * 2002-05-02 2005-04-14 주식회사 알로에마임 디팔미토일하이드록시프롤린과 소이이소플라본을 함유한리포좀 또는 나노에멀젼 및 이를 함유한 화장료 조성물 및그 제조방법
SI2108362T1 (sl) * 2002-06-26 2013-08-30 Medigene Ag Kationski nosilni sistem, ki vsebuje taksan
ES2331791T5 (es) 2002-06-26 2016-01-21 Medigene Ag Método de producción de una preparación catiónica de liposomas que comprende un compuesto lipófilo
US20050175683A1 (en) * 2003-10-24 2005-08-11 Yuanpeng Zhang Preparation of lipid particles
KR101462825B1 (ko) 2004-05-03 2014-11-21 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
ATE454884T1 (de) * 2004-10-18 2010-01-15 Polymun Scient Immunbio Forsch Liposomale zusammensetzung einen wirkstoff zur relaxierung glatter muskulatur enthaltend, die herstellung dieser zusammensetzung und deren therapeutische verwendung
JP2009510032A (ja) 2005-09-30 2009-03-12 リポクセン テクノロジーズ リミテッド 多糖抗原及びタンパク質アジュバントを含む多価リポソームワクチン組成物
RU2300369C1 (ru) * 2005-12-27 2007-06-10 Наталья Ивановна Ларионова Способ получения полиэлектролитных микрочастиц, содержащих инкапсулируемое вещество, чувствительных к изменению состава окружающей среды
EP2492278A1 (en) 2006-09-18 2012-08-29 Compugen Ltd. Antibodies against an agonist of G-protein coupled receptors and its use indiagnosis and therapy
CA2693651A1 (en) 2007-07-12 2009-01-15 Ronen Shemesh Bioactive peptides and method of using same
JP5362998B2 (ja) * 2008-01-10 2013-12-11 第一ファインケミカル株式会社 乾燥リポソーム製剤
US9445975B2 (en) 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
WO2010041255A2 (en) 2008-10-07 2010-04-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Liposomal systems comprising sphingomyelin
EP2184054A1 (en) 2008-11-08 2010-05-12 Lipoxen Technologies Limited Small Interfering RNA Delivery
WO2010140377A1 (ja) 2009-06-04 2010-12-09 独立行政法人産業技術総合研究所 マイコプラズマ感染症用ワクチン
RU2409668C1 (ru) * 2009-09-02 2011-01-20 Александр Анатольевич Ярославов Способ получения иммобилизованных бислойных везикул
KR20110068831A (ko) 2009-12-16 2011-06-22 재단법인 전라남도생물산업진흥재단 리포좀 조성물, 그 제조방법, 및 폐렴 백신으로서의 그 용도
FR2958851B1 (fr) * 2010-04-16 2012-06-29 Xeda International Nouvelles formulations d'ingredient(s) actif(s) d'origine vegetale ou leurs analogues synthetiques ou d'extrait(s) d'origine vegetale les contenant, et de lecithine
BR112013017267B1 (pt) 2011-01-04 2021-06-22 Archivel Farma, Sl Formulação de lipossomas, suspensão e composição farmacêutica
PT2768484T (pt) 2011-10-21 2019-10-28 Jazz Pharmaceuticals Res Llc Lipossomas liofilizados
IN2014MN01594A (enExample) 2012-01-12 2015-05-08 Archivel Farma Sl
EA023079B1 (ru) * 2012-12-24 2016-04-29 Общество С Ограниченной Ответственностью "Технология Лекарств" Способ получения липосомальной формы иринотекана (варианты)
JP6866060B2 (ja) * 2014-10-27 2021-04-28 花王株式会社 精製茶抽出物の製造方法
KR101739208B1 (ko) * 2014-12-30 2017-05-25 (주)셀트리온 표피성장인자와 리포좀의 하이브리드형 다중층 나노구조체 및 그 제조방법
WO2016191700A1 (en) * 2015-05-27 2016-12-01 Nuvox Pharma Llc Treatment of acute complications of sickle cell disease
WO2017049132A1 (en) * 2015-09-18 2017-03-23 DNARx Systems and methods for nucleic acid expression in vivo
ES3036518T3 (en) 2015-10-16 2025-09-19 Ipsen Biopharm Ltd Stabilizing camptothecin pharmaceutical compositions
EP3600428A4 (en) 2017-03-23 2020-08-26 Dnarx SYSTEMS AND METHODS FOR THE EXPRESSION OF NUCLEIC ACIDS IN VIVO
GB201707700D0 (en) 2017-05-12 2017-06-28 Glaxosmithkline Biologicals Sa Dried composition
RU2697802C1 (ru) * 2018-08-23 2019-08-20 Федеральное Государственное Бюджетное Учреждение Науки Институт Биохимической Физики Им. Н.М. Эмануэля Российской Академии Наук (Ибхф Ран) Способ получения магнитных липосом

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
EP0208764A4 (en) * 1985-01-11 1987-10-08 Univ California METHOD FOR PRESERVING LIPOSOMES.
CA1256372A (en) * 1985-04-11 1989-06-27 Koichiro Miyazima Process for producing liposome composition
US5094785A (en) * 1986-12-10 1992-03-10 Ciba Corning Diagnostics Corp. Process for stabilizing liposomes
AU612631B2 (en) * 1987-02-24 1991-07-18 Vestar, Inc. Dehydrating vesicule preparations for long-term storage
US5089181A (en) * 1987-02-24 1992-02-18 Vestar, Inc. Method of dehydrating vesicle preparations for long term storage
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
JP2780755B2 (ja) * 1987-05-22 1998-07-30 ザ リポソーム カンパニー，インコーポレイテッド プロスタグランジン‐脂質製剤
DE68916439T2 (de) * 1988-10-05 1994-10-20 Vestar Inc Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
RU2014071C1 (ru) * 1991-03-26 1994-06-15 Научно-производственный центр медицинской биотехнологии Способ получения липосом, содержащих водорастворимые низкомолекулярные соединения
US5958881A (en) * 1991-04-25 1999-09-28 Korman; Louis Y. Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
WO1993020802A1 (en) * 1992-04-09 1993-10-28 Northwestern University Acoustically reflective liposomes and methods to make and use the same
DK0678017T3 (da) * 1993-11-05 1998-10-19 Amgen Inc Liposomfremstilling og materialeindkapslingsfremgangsmåde
EP0914094A4 (en) * 1996-03-28 2000-03-01 Univ Illinois MATERIALS AND METHOD FOR PRODUCING IMPROVED LIPOSOMAL AGENTS
CA2202103C (en) * 1996-04-11 2007-01-09 Toshiaki Tagawa Method for preparing closed vesicles
JP3693209B2 (ja) * 1996-04-11 2005-09-07 三菱化学株式会社 閉鎖小胞の製造方法
RU2123328C1 (ru) * 1996-04-19 1998-12-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Липосомальное противовирусное лекарственное средство для перорального применения
NZ332666A (en) * 1996-05-08 2000-05-26 Nika Health Products Ltd Cationic virosomes having a positively charged lipid bilayer membrane with an integrated viral fusogenic peptide as genetic transfer systems for use in gene therapy

Similar Documents

Publication Publication Date Title
AU741784B2 (en) Modulation of drug loading in multivesicular liposomes
US4857319A (en) Method for preserving liposomes
KR920002300B1 (ko) 리포좀의 보존방법
KR100658956B1 (ko) 리포좀의 제조방법
EP0781123B1 (en) Preparation of multivesicular liposomes for controlled release of active agents
US4588578A (en) Lipid vesicles prepared in a monophase
US5262168A (en) Prostaglandin-lipid formulations
AU617678B2 (en) Prostaglandin-lipid formulations
RU2001101910A (ru) Способ получения липосом
AU587600B2 (en) Method for preserving liposomes
US6051251A (en) Liposome loading method using a boronic acid compound
Ahn et al. Proliposomes as an intranasal dosage form for the sustained delivery of propranolol
IL97538A (en) Multilamellar liposomes containing nonphosphate guanindino aminoglycosides and their preparation.
CN1044093C (zh) 低毒性药物类脂制剂
WO1997042936A1 (en) Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
HK1007496B (en) Prostaglandin-lipid formulations
Tari et al. Structure and function relationship of phosphatidylglycerol in the stabilization of phosphatidylethanolamine bilayer
Meyer et al. Efficient encapsulation of proteins within liposomes for slow release in vivo
EP0731703B1 (en) Liposomal formulations containing vidarabine or its derivatives
CA1330199C (en) Spontaneous vesiculation of multilamellar liposomes
JP2817883B2 (ja) 高度に完全なリポソームおよびその製剤法と用途
EP0382777B1 (en) Aqueous preparation of liposome composition
Kim et al. Effect of bovine serum albumin on the stability of methotrexate-encapsulated liposomes
Yachi et al. Pharmaceutical and biological properties of doxorubicin encapsulated in liposomes (L‐ADM): The effect of repeated administration on the systemic phagocytic activity and pharmacokinetics
US5419914A (en) Phospholipid analogue vesicle